These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 7443429

  • 1. [The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)].
    Jacotot B.
    Nouv Presse Med; 1980 Oct 30; 9(40):2951-4. PubMed ID: 7443429
    [No Abstract] [Full Text] [Related]

  • 2. [Antilipemics and atherosclerosis].
    Chiche P, Chekler P, Ribadeau-Dumas JL, Derrida R.
    Coeur Med Interne; 1967 Apr 30; 6(2):235-43. PubMed ID: 5618970
    [No Abstract] [Full Text] [Related]

  • 3. [Dyslipidemias and atherosclerosis. Treatment strategy].
    Pometta D.
    Schweiz Rundsch Med Prax; 1986 Sep 30; 75(40):1173-6. PubMed ID: 3775162
    [No Abstract] [Full Text] [Related]

  • 4. [A new therapeutic approach of associated metabolic diseases. 1 000 patients treated with benfluorex (author's transl)].
    Glikmanas M, Giraudet MC, Fould G.
    Sem Hop; 1986 Sep 30; 55(27-30):1305-11. PubMed ID: 228405
    [Abstract] [Full Text] [Related]

  • 5. Prevention and treatment of arteriosclerosis.
    DePalma RG.
    Compr Ther; 1992 Feb 30; 18(2):30-2. PubMed ID: 1547601
    [No Abstract] [Full Text] [Related]

  • 6. [Current treatment of the hyperlipoproteinemias. Risk factor for coronary disease].
    Gutiérrez Fuentes JA, Gutiérrez Yago JJ, Díez Monedero E.
    Med Clin (Barc); 1987 Jul 04; 89(6):253-7. PubMed ID: 3626690
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA, Oleĭnik NA, Valeeva RM, Pavlova TN.
    Sov Med; 1984 Jul 04; (1):83-7. PubMed ID: 6701660
    [No Abstract] [Full Text] [Related]

  • 8. [The risk and treatment of hyperlipoproteinemias].
    Alzamora P, Alegría E, Iglesias I.
    Rev Med Univ Navarra; 1990 Jul 04; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448
    [Abstract] [Full Text] [Related]

  • 9. High-density lipoprotein cholesterol-raising strategies.
    Kuvin JT, Alsheikh-Ali AA, Karas RH.
    J Cardiovasc Pharmacol; 2006 Feb 04; 47(2):196-204. PubMed ID: 16495756
    [Abstract] [Full Text] [Related]

  • 10. [Arteriosclerosis. IV. Treatment of dyslipoproteinemia].
    Cybulska B, Kłosiewicz-Latoszek L.
    Wiad Lek; 1985 Sep 01; 38(17):1251-7. PubMed ID: 4090499
    [No Abstract] [Full Text] [Related]

  • 11. [Vitamins in the prevention of hyperlipoproteinemia and atherosclerosis (author's transl)].
    Butturini U.
    Acta Vitaminol Enzymol; 1980 Sep 01; 2(5-6):135-46. PubMed ID: 7027763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].
    Arteaga A, Maiz A, Lathrop R.
    Rev Med Chil; 1981 Oct 01; 109(10):945-51. PubMed ID: 7344018
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Is research in the field of arteriosclerosis still worth while? (author's transl)].
    Schacht E, Marshall M.
    MMW Munch Med Wochenschr; 1981 Dec 18; 123(51-52):1965-9. PubMed ID: 6798433
    [No Abstract] [Full Text] [Related]

  • 19. [Serum lipids in correlation with the localizations of atherosclerosis. A preliminary statistical study of 1 511 cases (author's transl)].
    Bartolin R, Bouvenot G, Escande-Orthlieb M, Delboy C, Roux M.
    Sem Hop; 1981 Dec 18; 56(17-18):893-4. PubMed ID: 6248975
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.